Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience.

Becherucci V, Piccini L, Casamassima S, Bisin S, Gori V, Gentile F, Ceccantini R, De Rienzo E, Bindi B, Pavan P, Cunial V, Allegro E, Ermini S, Brugnolo F, Astori G, Bambi F.

Stem Cell Res Ther. 2018 May 2;9(1):124. doi: 10.1186/s13287-018-0863-8.

2.

Neuromyelitis optica, atypical hemophagocytic lymphohistiocytosis and heterozygous perforin A91V mutation.

Palterer B, Brugnolo F, Sieni E, Barilaro A, Parronchi P.

J Neuroimmunol. 2017 Oct 15;311:10-13. doi: 10.1016/j.jneuroim.2017.08.003. Epub 2017 Aug 15.

PMID:
28863861
3.

Extracorporeal photopheresis as an immunomodulatory agent: Haematocrit-dependent effects on natural killer cells.

Becherucci V, Allegro E, Brugnolo F, Piccini L, Gori V, Bisin S, Bindi B, Ceccantini R, Pavan P, Cunial V, Gentile F, Ermini S, Bambi F.

J Clin Apher. 2017 Aug;32(4):257-265. doi: 10.1002/jca.21490. Epub 2016 Jul 31.

PMID:
27476149
4.

Leukapheresis for autologous stem cell transplantation: Comparative study of two different thawing methods WSCFD(®) Stem Cell Fast Thawer KW versus 37 °C thermostatic bath.

Becherucci V, Piccini L, Gori V, Bisin S, Bindi B, Ceccantini R, Pavan P, Cunial V, Ermini S, Brugnolo F, Bambi F.

Transfus Apher Sci. 2015 Dec;53(3):342-7. doi: 10.1016/j.transci.2015.07.001. Epub 2015 Jul 14.

PMID:
26208787
5.

Genotype-phenotype study of familial haemophagocytic lymphohistiocytosis type 3.

Sieni E, Cetica V, Santoro A, Beutel K, Mastrodicasa E, Meeths M, Ciambotti B, Brugnolo F, zur Stadt U, Pende D, Moretta L, Griffiths GM, Henter JI, Janka G, Aricò M.

J Med Genet. 2011 May;48(5):343-52. doi: 10.1136/jmg.2010.085456. Epub 2011 Jan 19.

6.

Partial safety of the new COX-2 inhibitor rofecoxib in NSAIDs high sensitive patients.

Matucci A, Parronchi P, Vultaggio A, Rossi O, Brugnolo F, Maggi E, Romagnani S.

Allergy. 2004 Oct;59(10):1133-4. No abstract available.

PMID:
15355480
7.

The novel synthetic immune response modifier R-848 (Resiquimod) shifts human allergen-specific CD4+ TH2 lymphocytes into IFN-gamma-producing cells.

Brugnolo F, Sampognaro S, Liotta F, Cosmi L, Annunziato F, Manuelli C, Campi P, Maggi E, Romagnani S, Parronchi P.

J Allergy Clin Immunol. 2003 Feb;111(2):380-8.

PMID:
12589360
8.

Coronary vasospasm during an acute allergic reaction.

Matucci, Rossi O, Cecchi L, Vultaggio A, Parronchi P, Brugnolo F, Maggi E, Romagnani S.

Allergy. 2002 Sep;57(9):867-8. No abstract available.

PMID:
12169196
9.

Phosphorothioate oligonucleotides: looking for the motif(s) possessing immunostimulatory activities in humans.

Brugnolo F, Annunziato F, Sampognaro S, Manuelli C, Cosmi L, Romagnani S, Maggi E, Parronchi P.

Adv Exp Med Biol. 2001;495:261-4. No abstract available.

PMID:
11774576
10.

Reversal of human allergen-specific CRTH2+ T(H)2 cells by IL-12 or the PS-DSP30 oligodeoxynucleotide.

Annunziato F, Cosmi L, Manetti R, Brugnolo F, Parronchi P, Maggi E, Nagata K, Romagnani S.

J Allergy Clin Immunol. 2001 Nov;108(5):815-21.

PMID:
11692110
11.

Genetic and environmental factors contributing to the onset of allergic disorders.

Parronchi P, Brugnolo F, Sampognaro S, Maggi E.

Int Arch Allergy Immunol. 2000 Jan;121(1):2-9. Review.

PMID:
10686503
12.

Phosphorothioate oligodeoxynucleotides promote the in vitro development of human allergen-specific CD4+ T cells into Th1 effectors.

Parronchi P, Brugnolo F, Annunziato F, Manuelli C, Sampognaro S, Mavilia C, Romagnani S, Maggi E.

J Immunol. 1999 Dec 1;163(11):5946-53.

13.

Highly Th2-skewed cytokine profile of beta-lactam-specific T cells from nonatopic subjects with adverse drug reactions.

Brugnolo F, Annunziato F, Sampognaro S, Campi P, Manfredi M, Matucci A, Blanca M, Romagnani S, Maggi E, Parronchi P.

J Immunol. 1999 Jul 15;163(2):1053-9.

14.

Influence of both TCR repertoire and severity of the atopic status on the cytokine secretion profile of Parietaria officinalis-specific T cells.

Parronchi P, Sampognaro S, Annunziato F, Brugnolo F, Radbruch A, Di Modugno F, Ruffilli A, Romagnani S, Maggi E.

Eur J Immunol. 1998 Jan;28(1):37-46. doi: 10.1002/(SICI)1521-4141(199801)28:01<37::AID-IMMU37>3.0.CO;2-C.

15.

Pathogenesis and therapy of Behçet's disease.

Emmi L, Brugnolo F, Marchione T.

Ann Ital Med Int. 1997 Jan-Mar;12(1):20-5. Review.

PMID:
9284594
16.

Immunopathological aspects of Behçet's disease.

Emmi L, Brugnolo F, Salvati G, Marchione T.

Clin Exp Rheumatol. 1995 Nov-Dec;13(6):687-91. No abstract available.

PMID:
8835239
17.

Long term efficacy of high-dose intravenous methylprednisolone pulses in active lupus nephritis. A 21-month prospective study.

Bertoni M, Brugnolo F, Bertoni E, Salvadori M, Romagnani S, Emmi L.

Scand J Rheumatol. 1994;23(2):82-6.

PMID:
8165443

Supplemental Content

Loading ...
Support Center